Last edition
News about
After India, Innocan Pharma Secures Patent Allowance in Japan for Liposomal CBD Delivery Platform
Israel-based pharmaceutical technology company Innocan Pharma Corporation has announced that its patent for the liposomal delivery platform LPT-CBD has been allowed in Japan and will be officially granted following the completion of administrative process.
PENTAX Medical Sells C2 CryoBalloon Technology to Merit Medical Systems
PENTAX Medical, a division of the Japanese med-tech company HOYA Group and a global leader in flexible reusable endoscopy, has signed an asset purchase agreement with the American healthcare technology company Merit Medical Systems for the sale of its C2 CryoBalloon technology.
Becton Dickinson CFO Chris DelOrefice to Step Down; Vitor Roque Appointed Interim Successor
American medical technology giant Becton Dickinson and Co. (BD) has announced that Chris DelOrefice, Executive Vice President and Chief Financial Officer, will depart the company on December 5, 2025, to pursue a new professional opportunity.
Viatris Acquires Aculys Pharma, Secures Exclusive Rights to Pitolisant and Spydia in Japan
Viatris has completed the acquisition of Aculys Pharma, a clinical stage biopharmaceutical company focused on commercialising innovative treatments for neurological conditions.
Marksans Pharma's UK subsidiary Relonchem Secures MHRA Approval for Clonidine Tablets
Marksans Pharma’s wholly owned UK subsidiary, Relonchem, has received marketing authorisation from the UK Medicines & Healthcare products Regulatory Agency (MHRA) for Clonidine 100 microgram tablets and Clonidine Hydrochloride 25 microgram tablets.
AstraZeneca India to Launch Hyperkalaemia Treatment Lokelma in November 2025
AstraZeneca Pharma India Limited (AZPIL) has announced the upcoming launch of Sodium Zirconium Cyclosilicate powder for oral suspension 5g (Lokelma) in India in November 2025.
CPHI Frankfurt 2025: Marchesini Group to Showcase High-Speed AI-Powered Inspection Machine
Marchesini Group, a global leader in the development of complete lines for packaging and filling pharmaceutical and cosmetic products, will showcase a range of inspection, digitalisation, and laboratory innovations at CPHI Frankfurt 2025, taking place from October 28–30.
China Approves GSK's Shingrix for Shingles Prevention
The China National Medical Products Administration (NMPA) has approved GSK’s Shingrix (Recombinant Zoster Vaccine or RZV) for the prevention of shingles (herpes zoster) in adults aged 18 years and over who are at increased risk of shingles due to immunodeficiency or immunosuppression caused by known disease or therapy.
EY Acquires Aqurance to Boost Lifesciences Transformation on Veeva
The acquisition of Aqurance aims to strengthen the EY organisation’s Veeva Centers of Excellence, expanding clinical, regulatory and commercial services capabilities for global pharma and biotech.
Pfizer has announced positive topline results from its Phase 3 HER2CLIMB-05 trial evaluating TUKYSA (tucatinib) in combination with trastuzumab and pertuzumab as a first-line maintenance therapy for patients with HER2-positive (HER2+) metastatic breast cancer (MBC).
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy